SORBITRATE Drug Patent Profile
When do Sorbitrate patents expire, and what generic alternatives are available?
Sorbitrate is a drug marketed by Astrazeneca and is included in six NDAs.
The generic ingredient in SORBITRATE is isosorbide dinitrate. There is one drug master file entry for this compound. Eighteen suppliers are listed for this compound. Additional details are available on the isosorbide dinitrate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Sorbitrate
A generic version of SORBITRATE was approved as isosorbide dinitrate by PH HEALTH on March 12th, 1987.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for SORBITRATE?
- What are the global sales for SORBITRATE?
- What is Average Wholesale Price for SORBITRATE?
Summary for SORBITRATE
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 6 |
| Raw Ingredient (Bulk) Api Vendors: | 62 |
| Clinical Trials: | 1 |
| Patent Applications: | 4,238 |
| DailyMed Link: | SORBITRATE at DailyMed |
Recent Clinical Trials for SORBITRATE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| National Institute of Perinatology | Phase 4 |
| National Council of Science and Technology, Mexico | Phase 4 |
US Patents and Regulatory Information for SORBITRATE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Astrazeneca | SORBITRATE | isosorbide dinitrate | TABLET, CHEWABLE;ORAL | 016776-002 | Apr 1, 1996 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Astrazeneca | SORBITRATE | isosorbide dinitrate | TABLET;ORAL | 088125-001 | Aug 21, 1990 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Astrazeneca | SORBITRATE | isosorbide dinitrate | TABLET;ORAL | 016192-002 | Apr 1, 1996 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Astrazeneca | SORBITRATE | isosorbide dinitrate | TABLET;SUBLINGUAL | 016191-002 | Apr 1, 1996 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Astrazeneca | SORBITRATE | isosorbide dinitrate | TABLET, CHEWABLE;ORAL | 016776-003 | Apr 1, 1996 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Astrazeneca | SORBITRATE | isosorbide dinitrate | TABLET;ORAL | 016192-001 | Apr 1, 1996 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
